Tumor Inhibitory Effect of IRCR201, a Novel Cross-Reactive c-Met Antibody Targeting the PSI Domain

Hepatocyte growth factor receptor (HGFR, c-Met) is an essential member of the receptor tyrosine kinase (RTK) family that is often dysregulated during tumor progression, driving a malignant phenotypic state and modulating important cellular functions including tumor growth, invasion, metastasis, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Hyunkyu, Kim, Donggeon, Kim, Eunmi, Sa, Jason K., Lee, Hee Won, Yu, Suji, Oh, Jiwon, Kim, Seok-Hyung, Yoon, Yeup, Nam, Do-Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618617/
https://www.ncbi.nlm.nih.gov/pubmed/28902178
http://dx.doi.org/10.3390/ijms18091968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618617/
https://www.ncbi.nlm.nih.gov/pubmed/28902178
http://dx.doi.org/10.3390/ijms18091968

Ejemplares similares